Product Description: CK1-IN-1 is a casein kinase 1 (CK1) inhibitor extracted from patent WO2015119579A1, compound 1c, has IC50s of 15 nM, 16 nM, 73 nM for CK1δ, and CK1ε, p38σ MAPK, respectively[1].
Applications: COVID-19-anti-virus
Formula: C24H15F2N3
References: [1]Filip LACO,et al. 2,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis. WO2015119579A1.
CAS Number: 1784751-20-7
Molecular Weight: 383.39
Compound Purity: 99.35
Research Area: Inflammation/Immunology
Solubility: DMSO : 62.5 mg/mL (ultrasonic)
Target: Casein Kinase